Type I IFN deficiency: an immunological characteristic of severe COVID-19 patients

Signal Transduct Target Ther. 2020 Sep 14;5(1):198. doi: 10.1038/s41392-020-00306-4.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Betacoronavirus*
  • COVID-19
  • Coronavirus Infections*
  • Humans
  • Interferon Type I*
  • Pandemics*
  • Pneumonia, Viral*
  • SARS-CoV-2

Substances

  • Interferon Type I